Market Tracker

03/28 5:16pm ET

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.40
Delayed Data
As of 3:59pm ET
 +0.04 / +1.19%
Today’s Change
2.85
Today|||52-Week Range
5.13
-3.95%
Year-to-Date

Today’s Trading

Previous close3.36
Today’s open3.35
Day’s range3.29 - 3.41
Volume1,739,073
Average volume (3 months)1,956,049
Market cap$414.0M
Dividend yield--
Data as of 3:59pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)+3.05%
Earnings growth (this year)+5.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+23.83%
P/E ratioNM
Price/Sales52.96
Price/Book1.53

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...0.000.00%
OXFDOxford Immunotec Glo...0.000.00%
VCYTVeracyte Inc-0.06-0.66%
CALACalithera Bioscience...+0.10+0.94%
Data as of 3:59pm ET, 03/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$6.8M
Annual profit (last year)-$128.5M
Net profit margin-1,894.05%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts